Vaccines are the best weapons to protect the individuals against infection or disease by stimulating the bodyâs immune system. Unfortunately, vaccines against HIV are in various stages of clinical trial, but none of the trails were successful to provide protection against HIV. Researchers do not have clear initiative as the virus has unique ways of evading the immune system, and the human body seems to be incapable of mounting an effective immune response against it. NIAID, UNAIDS and WHO support many biomedical research works to develop an effective, safe and durable vaccine against the HIV by enhancing the effectiveness of existing prevention strategies to control the HIV/AIDS.
Open access to the scientific literature means the removal of barriers (including price barriers) from accessing scholarly work. There are two parallel âroadsâ towards open access: Open Access articles and self-archiving. Open Access articles are immediately, freely available on their Web site, a model mostly funded by charges paid by the author (usually through a research grant).
Open Access raises practical and policy questions for scholars, publishers, funders, and policymakers alike, including what the return on investment is when paying an article processing fee to publish in an Open Access articles, or whether investments into institutional repositories should be made and whether self-archiving should be made mandatory, as contemplated by some funders.
Last date updated on August, 2020